Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$101.3M
+125.1% from 2023
Prescriptions
3,241
$31,247.38 per claim
Patients
380
300 prescribers
Total spending, 2024
$101.3M
$266,507.24 per patient
Medicare prescription drug plans paid $101.3M for Skyclarys in 2024, for 3,241 prescriptions and refills to 380 patients (up 125.1% from 2023). The average cost per claim was $31,247.38.
Pennsylvania had the highest Medicare cost for Skyclarys in 2024: $10.4M for 351 claims, followed by California ($9.8M).
David R Lynch, neurology in Philadelphia, PA, had the highest Medicare cost for Skyclarys in 2024: 337 claims costing $10.0M.
Skyclarys is made by Biogen Inc. (BIIB), listed in the Medicare spending data as Reata/Biogen.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| David R Lynch Philadelphia, PA | Neurology | 337 | 39 | $10.0M |
| Susan L Perlman Los Angeles, CA | Neurology | 132 | 17 | $4.0M |
| Khalafalla Bushara |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2023 | 224 | 1,428 | 321 | $45.0M |
| 2024 | 300 | 3,241 | 380 | $101.3M |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims |
|---|
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Neurology |
| 41 |
| Under 11 |
| $1.6M |
| Randal C Richardson Saint Paul, MN | Neurology | 49 | Under 11 | $1.6M |
| Christopher Gomez Chicago, IL | Neurology | 47 | Under 11 | $1.5M |
| Katherine D Mathews Iowa City, IA | Neurology | 42 | Under 11 | $1.2M |
| Joseph C Hoyle Dublin, OH | Neurology | 39 | Under 11 | $1.2M |
| Sankarasubramoney H Subramony Gainesville, FL | Neurology | 39 | Under 11 | $1.1M |
| Nicholas E Johnson Salt Lake City, UT | Neurology | 34 | Under 11 | $1.1M |
| Robert M Pascuzzi Indianapolis, IN | Neurology | 33 | Under 11 | $1.1M |
| Jeremy Schmahmann Boston, MA | Neurology | 26 | Under 11 | $985K |
| Tarek Ali Lexington, KY | Neurology | 28 | Under 11 | $912K |
| Nassim Rad Seattle, WA | Physical Medicine and Rehabilitation | 27 | Under 11 | $858K |
| Yasushi Kisanuki Gahanna, OH | Neurology | 25 | Under 11 | $807K |
| Sarah J Doss Kearney, NE | Neurology | 25 | Under 11 | $780K |
| Christopher L Groth Iowa City, IA | Neurology | 24 | Under 11 | $778K |
| Holli A Horak Tucson, AZ | Neurology | 24 | Under 11 | $765K |
| Jaime Halverson Walker, MI | Family Practice | 24 | Under 11 | $763K |
| Anne E Youngling Guilford, CT | Family Practice | 24 | Under 11 | $750K |
| Sahyli Perez Parra Atlantis, FL | Neurology | 23 | Under 11 | $742K |
| Cori J Shope Wilmington, NC | Pharmacist | 24 | Under 11 | $741K |
| Paul G Genilo Wichita, KS | Neurology | 26 | Under 11 | $738K |
| Nicholas E Rome Columbus, IN | Neurology | 23 | Under 11 | $725K |
| George R Wilmot III Atlanta, GA | Neurology | 23 | Under 11 | $719K |
| Jeffrey L Elliott Dallas, TX | Neurology | 22 | Under 11 | $711K |
| Spending |
|---|
| Reata/Biogen BIIB | 3,241 | $101.3M |